A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Conditions
Kidney Disease · Renal Insufficiency Chronic · Kidney Failure, Chronic · Renal Impairment · Renal Insufficiency · End Stage Kidney Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Floridian Clinical Research, LLC, Miami Lakes, Florida, United States
Contact: Principal Investigator (Pedro Hernandez)Omega Research Orlando LLC, Orlando, Florida, United States
Contact: Principal Investigator (Kwabena Ayesu)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company